Study S002624

A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07194317
Acronym: FIDGET
Study type: INTERVENTIONAL
Masking: NONE
Status: COMPLETED
Enrollment: 64
Start: 2025-09-01
Primary completion: 2026-03-13
Lead sponsor: King's College London
Conditions: Obese Patients
Interventions: DEVICE:Testing 3 different digital dietary assessment tools in a random order (Nutritics-Libro, MyFood24 and Intake24)
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Usability [Following each test period of 1 week]
Usability and context of use [Following each test period of 1 week]]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0006212	Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs. Christensen S, Obesity pillars	2024	Narrative review	PMID 39175746 DOI	registry reference RESULT:39175746
R0015900	Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions. Astrup A, European journal of clinical nutrition	2024	Narrative review	PMID 38890501 DOI	registry reference RESULT:38890501